- Home
- PEPG vs USNA Comparison
PEPG vs USNA Comparison
Compare PEPG & USNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PEPG
- USNA
- Stock Information
- Founded
- PEPG 2018
- USNA 1992
- Country
- PEPG United States
- USNA United States
- Employees
- PEPG N/A
- USNA N/A
- Industry
- PEPG Biotechnology: Pharmaceutical Preparations
- USNA Medicinal Chemicals and Botanical Products
- Sector
- PEPG Health Care
- USNA Health Care
- Exchange
- PEPG Nasdaq
- USNA Nasdaq
- Market Cap
- PEPG 317.6M
- USNA 349.7M
- IPO Year
- PEPG 2022
- USNA 1996
- Fundamental
- Price
- PEPG $5.70
- USNA $18.57
- Analyst Decision
- PEPG Strong Buy
- USNA Hold
- Analyst Count
- PEPG 6
- USNA 1
- Target Price
- PEPG $9.50
- USNA $36.00
- AVG Volume (30 Days)
- PEPG 708.7K
- USNA 390.9K
- Earning Date
- PEPG 11-12-2025
- USNA 10-22-2025
- Dividend Yield
- PEPG N/A
- USNA N/A
- EPS Growth
- PEPG N/A
- USNA N/A
- EPS
- PEPG N/A
- USNA 0.90
- Revenue
- PEPG N/A
- USNA $912,670,000.00
- Revenue This Year
- PEPG N/A
- USNA $9.87
- Revenue Next Year
- PEPG N/A
- USNA N/A
- P/E Ratio
- PEPG N/A
- USNA $20.87
- Revenue Growth
- PEPG N/A
- USNA 5.88
- 52 Week Low
- PEPG $0.88
- USNA $18.52
- 52 Week High
- PEPG $6.85
- USNA $40.79
- Technical
- Relative Strength Index (RSI)
- PEPG 63.13
- USNA 28.94
- Support Level
- PEPG $4.71
- USNA $18.69
- Resistance Level
- PEPG $5.20
- USNA $19.24
- Average True Range (ATR)
- PEPG 0.46
- USNA 0.69
- MACD
- PEPG 0.07
- USNA 0.16
- Stochastic Oscillator
- PEPG 84.25
- USNA 5.13
About PEPG PepGen Inc.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.
About USNA USANA Health Sciences Inc.
Usana Health Sciences Inc is a direct selling and direct-to-consumer nutrition, personal health and wellness company. It developed and manufactured science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness. The company has two reportable segments: direct selling and Hiya direct-to-consumer. The direct selling segment develops and manufactures high quality, science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness in various geographic markets that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children's health and wellness products in the U.S. Key revenue is generated from Direct selling segment.